This document sets out recommendations and guidelines for submitting data in addition to the toxicological data recommended in Part 3 to enable the characterisation of the human health risks associated with the use of veterinary chemical products, as part of applications for registration or extensions of use and for permit applications.

The human exposure, hazard and risk data provide essential information on:

  • the human health hazards of the product
  • potential exposure during handling or use of the product by professional and/or domestic users
  • potential post-application exposure, such as during re-handling of treated animals after spot-on or other dermally applied treatments.

Risks to people’s health and safety are assessed by taking into account the hazard and the potential for exposure, using the following approach:

  • Hazard evaluation—The identification of the type and nature of adverse effects that a substance has an inherent capacity to cause in an organism, animal species or human. The data relating to hazard identification are discussed in detail in Part 3 (Toxicology)
  • Hazard characterisation (often referred to as the dose response characterisation)—The qualitative and, wherever possible, quantitative description of the inherent property of a substance having the potential to cause adverse effects. This should, where possible, include a dose–response assessment and its attendant uncertainties.
  • Exposure assessment—Evaluation of human exposure to a substance based on measured, extrapolated and/or modelled exposure data for the situation. 
  • Risk characterisation—The qualitative and, wherever possible, quantitative determination, including attendant uncertainties, of the probability that the adverse effect will occur in a given organism, animal species or humans under defined exposure conditions.
  • Based on the risk assessment, risk management measures can be undertaken to reduce human health risks to an acceptable level where necessary. Those measures include engineering controls, safety directions (including for personal protective equipment), use restraints, re-handling intervals, and scheduling recommendations.

1. Types of applications

The nature of the application determines which types of data you should provide. Each data module below lists a number of data elements.

You should submit data to provide a comprehensive view of the hazard, exposure and risk throughout the lifecycle of the product.

A comprehensive assessment comprises of a full occupational health and safety data package, containing all of the data elements; a reduced or limited assessment comprises a subset of the data elements in a comprehensive assessment.

Exposure studies should be conducted and interpreted using Organization for Economic Co-operation and Development (OECD), or similar, testing guidelines.

2. Data elements

The data elements for a comprehensive assessment are listed and, where necessary, explained in this section.

For some applications, certain studies may not be relevant because of the type of active constituent or product, or because of the intended use of the product. However, for certain veterinary chemical products, there may be specific considerations, recommendations, or both. You should address these considerations on a case-by-case basis and provide specific information as appropriate.

If you do not believe that a particular data element is necessary, you may leave the data heading in and provide a valid scientific argument for the exclusion of the data element. The regulatory value of scientific arguments will be determined based on their merits and reliability.

Additional regulatory information, including recommendations made by other governments and internationally recognised organisations, may also be considered during the assessment process.

The data elements for a comprehensive part 6 occupational health and safety submission are shown below. All data elements should be addressed with the submission of data or scientific argument.

The data elements are:

  • Contents
  • Data summary
  • Hazard
    • Physical and chemical properties (see chemistry and manufacture guidelines):
      • Active constituent
      • Product
      • Individual constituents
    • Toxicology (see ‘toxicology’)
  • Exposure
    • Mixing and loading
    • Product application
    • Re-handling
    • Dermal absorption
  • Risk characterisation
    • Margin of exposure (MOE)
    • Further requirements where the MOE is inadequate
    • Risk assessment proposed by the applicant (acute and repeat dose)
  • Risk management and workplace information
    • Measures to control occupational and public or domestic risks
      • Before and during end-use
      • Re-handling
    • Proposed label wording
    • Safety data sheet (SDS)
    • Training requirements
    • Occupational exposure monitoring
      • Exposure standard
      • Ambient air monitoring
      • Health surveillance
    • Contraindications

If any of this information has been supplied elsewhere in the application, it need not be repeated. You may simply cross-reference its location in the application.

Tables may be used as a means of summarising the information. If studies are cited, they should be cross-referenced in the main body of the application.

In the following sections we discuss briefly the information we expect under the headings we provided.

2.1. Contents

A table of contents should be provided.

2.2. Data summary

You should include an overall summary of the information and the rationale for any conclusions you make. The summary should contain:

  • a brief description of the product (including formulation type, hazard classification and packaging)
  • a brief description of the use pattern of the product (including purpose of application, equipment used and the maximum number of animals treated per day or the quantity of product handled per day)
  • an outline of the potential for workplace and/or domestic exposure (for example, during mixing, loading, dosing or application or re-handling)
  • an assessment of health risks to all exposed populations (workers, public)
  • a description of risk mitigation or reduction measures, where possible (such as safety directions, use restraints or restrictions, re-handling intervals or engineering controls).

2.3. Hazard

2.3.1. Physical and chemical properties

2.3.1.1. Active constituent

You should provide the following data elements for an active constituent and/or product:

  • International Union of Pure and Applied Chemistry (IUPAC) name
  • Chemical Abstract Service (CAS) number
  • purity
  • colour and physical appearance
  • odour
  • vapour pressure or volatility
  • octanol–water partition coefficient (Low Pow)
  • molecular weight
  • hazard classification
  • Australian Code for the Transport of Dangerous Goods by Roads and Rail (ADG Code)
  • packaging information.
2.3.1.2. Product

You should provide the following information:

  • formulation type
  • colour and physical appearance
  • odour
  • vapour pressure
  • volatility
  • hazardous properties
  • ADG code
  • dry particulate formulations:
    • particle size distribution
    • dust or fines content
    • attrition and friability
    • packaging information.
2.3.1.3. Individual constituents

You should provide the following information:

  • name (active constituents first, followed by non-active constituents)
  • CAS number
  • hazard classification
  • exposure standard (Safe Work Australia Hazardous Substances Information System, HSIS)
  • concentration.
2.3.1.3.1. IUPAC name, CAS number, purity, colour and physical appearance, odour, vapour pressure or volatility

In some instances, the data may be descriptive (colour, appearance, odour, etc.), whereas quantitative data for other properties (vapour pressure or volatility, etc.) should be provided.

2.3.1.3.2. Hazardous properties

Hazardous properties include properties adverse to human health recognised under the Safe Work Australia guidance to classifying hazardous chemicals (Safe Work Australia 2018), or the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), such as corrosive, carcinogenic, mutagenic and irritant.

Also included are physicochemical properties recognised under the ADG Code, such as explosive, flammable and oxidiser.

2.3.1.3.3. ADG Code

The ADG Code is implemented by state and territory legislation. For current information on the code, visit the National Transport Commission website.

2.3.1.3.4. Packaging information

This should include the container volume or weight, the container construction material, and the neck size of the container if its contents are a liquid. Any unique packaging information should also be provided (such as child-proof packaging or applicators such as syringes).

2.3.1.3.5. Formulation type

This should be consistent with types listed in the Handbook of first aid instructions and safety directions for agricultural and veterinary chemicals (FAISD Handbook).

2.3.1.3.6. Dry particulate formulations

Dusts, powders and granulates may be a risk to workers as a potential source of respirable particles. Therefore, you should provide the following information:

  • the particle size distribution (or nominal size range) for solid products intended for either direct application or for dispersion in water
  • the dust or fine content of particulate products in order to determine the percentage of respirable particles for classification purposes
  • estimates for attrition and friability for granular products to determine whether the capacity for dust generation meets the criteria for classification as a hazardous substance.
2.3.1.3.7. Hazard classification

Classification of hazardous substances is required under state and territory legislation. In the first instance, you should check the Safe Work Australia HSIS to determine whether the chemical has been previously classified as hazardous. If it has not been classified, it should be classified by referring to the Approved criteria for classifying hazardous substances (Safe Work Australia 2018, or the latest edition).

The GHS came into effect with new work health and safety laws on 1 January 2012. The GHS is an internationally agreed system designed to harmonise the diverse systems of classification and hazard communication currently in use throughout the world. Manufacturers and importers of hazardous chemicals will need to reclassify their products, re-label them and prepare new safety data sheets to meet the new requirements. There will be a five-year transitional period for moving to the new GHS-based system, during which manufacturers and importers can use either the GHS system or the current classification and labelling system for workplace hazardous substances and dangerous goods. After 1 January 2017, all chemicals supplied for use must comply with the new requirements. These changes do not apply to requirements under the ADG Code for the transport of dangerous goods. For more information about the changes, visit the hazardous chemicals pages on the Safe Work Australia website.

2.3.1.4. Toxicology

A full description of the relevant toxicological data elements is provided in Part 3 of the data guidelines (Toxicology). If these data have been supplied elsewhere in the application, you need only make a cross-reference to their location.

2.4. Exposure

Your submission should contain information relevant to all potential sources of exposure (occupational, public, domestic) to the active constituent and/or product. The data should allow a detailed assessment of the exposure, which is required to assess the risk to human health. Data that do not enable independent evaluation may be of reduced or no regulatory value.
Exposure-related data may be derived from various sources, such as measured user exposure or rehandling exposure studies, or from extrapolations based on surrogate data or suitable data models.

In general, data obtained from studies conducted under normal use conditions are preferred. However, calculations based on modelling or surrogate data may show that potential exposure levels associated with a particular use pattern are low enough not to warrant measured exposure studies. Where the calculations reveal a cause for concern, it may be appropriate to conduct measured studies to confirm or eliminate those concerns.

A variety of databases and models, which continue to be developed and improved, are used to estimate exposure. If you submit data derived from surrogate data or modelling, you should provide full disclosure of the source. Measured exposure data may also be drawn from published and unpublished studies. The exposure studies should contain sufficient data to allow independent evaluation of the findings, but published reports often do not have data to that level of detail and may be of reduced or no regulatory value.

2.4.1. Mixing and loading

Many products require preparation before application or end use. In most cases, this simply involves diluting the concentrated product with water. The risk of exposure for the worker doing the mixing is often significant.

Data elements to supply for veterinary chemical products are:

  • equipment or system
  • container volume(s)
  • container design (devices to reduce spillage)
  • tank or sump volume for animal sprays or dips
  • average number of mixing or loading operations per day
  • duration of treatment season
  • volume of product used per day
  • proposed personal protective equipment
  • exposure studies (if available) or modelled exposure data
  • other relevant information.

You should address any issues relevant to the use pattern described in the proposed wording for a label and other activities that may result in exposure to the chemical. If there are unusual circumstances in which additional information is needed for an effective assessment, you should submit that information.

2.4.1.1. Equipment or system

You should propose measures to control exposure.

Mixing and loading systems may be closed or open. Closed systems use engineering control measures to minimise the release of the product during mixing and loading. An example is the use of specifically designed product containers that fit directly to enclosed mixing tanks. Systems such as those may effectively mitigate the potential for exposure, such as through splashing or evaporation, that exists with open systems.

2.4.1.2. Container volume

This refers to the product container and need not be submitted again if provided earlier.

2.4.1.3. Average number of mixing or loading operations per day

This should be based on the typical use pattern of the product. A number of examples may be provided.

2.4.1.4. Duration of treatment season

Information on the treatment season for specific animal infestations or diseases indicated on the label will make the risk assessment more accurate. If a simple statement of a period of time does not adequately describe the situation, you should provide parameters such as the length of the treatment season (treatment months) or the number of operations per season (single application per season, regularly repeated treatments etc.).

2.4.1.5. Volume of product used per day

This should be consistent with the information above, based on the proposed use pattern described on the label. For ectoparasiticide dipping or jetting, you should provide the size of dipping tanks or jetting volumes.

2.4.1.6. Proposed personal protective equipment

This should be selected to minimise exposure to the chemical in question.

2.4.2. Product application

Veterinary chemical may be applied using many different methods and techniques, all of which have the potential to expose workers to them. Data relevant to the specific use pattern on the label makes it possible to assess potential exposure.

Data elements to supply for veterinary chemical products are:

  • use situation or animals to be treated
  • application method or equipment used (oral drenching, pour-on, jetting, dipping, injections, implants, in-feed/water etc.)
  • application rate per animal and frequency of application
  • expected maximum number of animals to be treated per day depending on farm sizes
  • total time (hours) for application per day
  • proposed personal protective equipment
  • worker exposure studies (if available) or a suitable model
  • other relevant information.

You should address any issues relevant to the use pattern described on the label and other activities that may result in exposure to the chemical. While these data elements may be adequate for most exposure assessments, there may be unusual circumstances in which additional information is needed for an effective assessment. Where that is the case, you should submit that information.

2.4.2.1. Use pattern

The use pattern, including a description of the class of animal, method and route of administration, frequency of dosing, duration of treatment, and other information relevant to how the product will be used, should be provided. You should provide enough information on the use of the substance to enable an accurate exposure assessment (such as indoor or outdoor use, use by veterinarians, public use in domestic situations).

2.4.2.2. Application method or equipment

Many application methods and types of equipment are used to apply/administer veterinary chemical products. The application method should be clearly indicated (such as injections, tablets, implants, oral drenches, pour-on applications, backline application, dipping, jetting, in-feed/water etc.). The type of application equipment (for example, low or high pressure applicator) and the method of droplet production (if applicable) should be clearly described.

Diagrams and/or photographs should be provided for product-specific application equipment (this is not necessary for common methods of applying/administering veterinary chemical products).

2.4.2.3. Application rate

The maximum and minimum product application rates (e.g. milligrams or millilitres per kilogram bodyweight for animals, grams per litre for dips) should be provided to estimate the maximum possible product use by workers.

If it is not possible to provide an application rate per animal, provide a total quantity of product handled per day, along with information supporting or justifying the figure.

2.4.2.4. Total time for application per day

This should be based on the number of animals treated per day, considering differences in farm sizes, equipment used and whether contract workers will apply the product. This information should be supported by data, if data are available.

2.4.2.5. Proposed personal protective equipment

This should be selected to protect users from identified acute and chronic health effects from the chemical in question.

If a specific glove type is required, the properties of the recommended type should be provided, taking into account the formulation characteristics, the breakthrough time of the glove material and practical issues for the user (such as availability and the feasibility of wearing the gloves during use of the product).

Details of respirators or any other equipment should be provided, taking into account practical issues for the user.

If you have additional information about the use of personal protective equipment for a particular use pattern or information on the standard practice for a particular industry, you should provide it.

The safe use of domestic veterinary chemical products should not require safety equipment that is not readily available to the householder. Protective equipment other than gloves is not considered a mitigation option for users of domestic veterinary chemical products because they are not trained and their compliance is not expected. Veterinary chemical products may not be supported for domestic use if protective equipment other than gloves is required for their safe use.

2.4.3. Re-handling

Exposure to veterinary chemical residues or their degradation products may be possible after a treatment has been completed, depending on the treatment method (for example, through re-handling treated animals immediately after pour-on or spot-on application). You should check whether there are specific re-handling recommendations as an outcome of an APVMA review (such as the review of sheep ectoparasiticide products).

Data elements to provide (where relevant) are:

  • task-specific worker exposure studies
  • animal re-handling studies or dislodgeable residues studies
  • proposed personal protective equipment
  • proposed restricted re-handling period.
2.4.3.1. Task-specific worker exposure studies

These should be submitted if available. Studies should be based on the specific re-handling tasks in question (for example, shearing after a sheep ectoparasiticide application).

In the absence of exposure studies, you may use default parameters, such as generic residue transfer coefficients and numbers of animal pettings.

2.4.3.2. Animal re-handling studies or dislodgeable residues studies

Re-handling studies describe expected handling activities (wool shearing, animal petting, etc.) after the application of a veterinary chemical product. Dislodgeable residues studies are used in calculating the levels of substance present and potentially transferable to users following treatment (such as transfer coefficient values or dissipation rates).

2.4.3.3. Proposed personal protective equipment

For workers involved in re-handling, this should be selected to protect them from acute and chronic health effects identified for the chemical in question.

Re-handling considerations for veterinary chemical products used in the domestic environment should not require any protective equipment other than gloves.

2.4.3.4. Proposed restricted re-handling period

You may propose a restricted re-handling period in order to protect workers from acute and chronic health effects identified for the substance in question.

Any proposed re-handling period for products applied in the domestic environment would need to take into account practicality and potential noncompliance. In addition, consideration of sensitive individuals (toddlers, children) is needed if exposure to product residues from routes other than dermal contact may occur (such as hand-to-mouth exposure).

2.4.4. Dermal absorption

An investigation of the extent of dermal absorption of the active constituent or product is desirable for risk assessment. In the absence of dermal absorption data, a default value of 100% substance applied to the skin is assumed as a worst case value. Applicants can refine the dermal absorption value by exploring further sources of information to estimate dermal absorption. For instance, the amount considered absorbable may be reduced by an applicant giving consideration to a substance’s specific physicochemical properties; so, for example, if a substance has a molecular weight of greater than 500 and a partition coefficient (log Pow) less than -1 or greater than 4, the default will be reduced from 100 to 10 per cent dermal absorption.

For dermal absorption studies provided in support of an application, the tested formulation should be identical to or closely resemble the product under consideration. The adequacy of this similarity will be determined on a case-by-case basis. Tested concentrations should represent expected human exposure concentrations (for example, the concentration of chemical in the product and the proposed end-use concentration[s] should be tested). Submission of ‘triple pack’ in vitro dermal absorption studies (using rat skin, human skin and an in vivo rat dermal study) is recommended to enable likely human dermal absorption to be estimated. The adequacy of dermal absorption data that does not follow the ‘triple pack’ approach will be assessed on a case-by-case basis, but those data may be of reduced value for risk assessment.

Further guidance on conducting and interpreting dermal absorption studies is in the OECD Guidance notes on dermal absorption.

2.5. Risk characterisation

2.5.1. Margin of exposure

A deterministic approach should be adopted for the risk assessment if adequate toxicological and exposure data are available. An acceptable margin between the relevant toxicological end-point (no-observed-effect level, or NOEL) and the measured or estimated repeated exposure is relevant in demonstrating the safety of the product. This is often called the margin of safety (MOS) or margin of exposure (MOE) and accounts for a range of uncertainties in the human health risk assessment. The acceptable margin varies depending on a range of factors, including:

  • the quality of the data on which the predicted margin is based
  • the toxicokinetics and/or toxicodynamics of a compound
  • the nature and severity of the toxic effects
  • the dose–response relationship
  • the type of data (for example, animal or human toxicology data).

As a general rule, for human health risk assessment purposes an MOE greater than 100 is required when using animal toxicology data and an MOE greater than 10 is required when using human toxicology data.

2.5.2. Further recommendations where the MOE is inadequate

If your preliminary risk assessment (for example, using surrogate data or an exposure model) indicates an unacceptable MOE, and all available risk management options (including personal protective equipment) have been taken into account, we recommend that you collect further data and refine the risk assessment. Refinements may include:

  • a percutaneous absorption study
  • a worker exposure study using the product submitted for registration
  • animal re-handling studies
  • animal coat residue dissipation studies
  • additional risk management strategies.

Human exposure studies should be conducted in accordance with current best practice.

The OECD’s Guidance document for the conduct of studies of occupational exposure to pesticides during agricultural application (OECD 1997) provides guidance on worker exposure studies and general guidance on minimum requirements for studies. The guidelines in general can also be applied to veterinary chemical product exposure assessment. This guidance is not as prescriptive as the United States Environmental Protection Agency’s Occupational and residential exposure test guidelines (US EPA 2013) and requires study authors to design the details of studies to suit the particular situation to be assessed.

Australian studies involving workers must comply with National Health and Medical Research Council guidelines, including the National statement on ethical conduct in research involving humans (NHMRC 2007).

2.5.3. Risk assessment proposed by the applicant

We encourage you to undertake a risk assessment using the information in your application. This can be done by comparing relevant toxicological end points and exposure information (either measured or extrapolated) for all likely target populations (workers, general public).

Publicly available assessment reports provide examples of the human health and safety risk assessment process. They will be most relevant if they are on a similar product type and are recent (because methods have improved over time).

Documents that provide some advice on risk assessment include:

2.6. Risk management and workplace information

2.6.1. Measures to control user exposure

We encourage you to submit risk management strategies and propose specific use information. Where indicated by the risk assessment, measures may be needed to control exposure to the substance before, during and/or after end use.

Where possible, you should quantify the level of protection afforded by controls (including the use of personal protective equipment) using available risk assessment methods. The controls should be sufficient to reduce exposure to a level that provides an acceptable MOE, as outlined above.

We encourage you to consider various measures to minimise exposure in accordance with the hierarchy of control measures in the National code of practice for the control of workplace hazardous substances (NOHSC 2007).

2.6.2. Proposed label wording

2.6.2.1. New active constituents

For new active constituents, if the isolated active constituent will be handled by Australian workers, you should provide a copy of the proposed label wording required under national and state and territory regulations.

2.6.2.2. Existing active constituents

For existing active constituents, a copy of the proposed label wording need not be submitted.

2.6.2.3. New products or existing product variations

For new products or variations to existing products that require an occupational health and safety assessment, the proposed label wording should be submitted.

2.6.3. Safety data sheet

A safety data sheet (SDS) should be included for:

  • new active constituents that are classified as hazardous according to the Safe Work criteria or the GHS and will be handled by Australian workers
  • products classified as hazardous according to the Safe Work criteria and according to the GHS.

The SDS for active constituent and product must be written in accordance with the National code of practice for the preparation of material safety data sheets (NOHSC–ASCC 2011).

The health effects information in the SDS for a new active constituent should be consistent with the information in the relevant particulars for a label. The label also contains first aid instructions and safety directions from the FAISD Handbook.

2.6.4. Training requirements

In some circumstances, training in the use of a product may be required for workplace safety reasons or under state and territory legislation (such as for Schedule 7 substances listed in Appendix J of the Standard for the Uniform Scheduling of Medicines and Poisons) . For example, the product may require the use of dedicated application equipment, or it may be very toxic. You should provide information on appropriate industry guidelines or any special training or accreditation required by a relevant authority for the use of the product.

2.6.5. Occupational exposure monitoring

Occupational exposure monitoring may be recommended in order to confirm that exposure is controlled. This may be by means of atmospheric monitoring, health surveillance, or both. Inhalation exposure monitoring should be part of any worker exposure study, unless inhalation has been shown to be a minor route of exposure.

For new active constituents, you should indicate whether exposure monitoring is appropriate. If so, provide an exposure limit, a justification for the limit and the proposed monitoring method.

2.6.6. Exposure standard

This refers to national exposure standards declared under the adopted national exposure standards for atmospheric contaminants in the occupational environment (Safe Work Australia, 2019). These values are established for the airborne concentration of an individual chemical at a level that should not cause adverse health effects or cause undue discomfort to nearly all workers.

You should check Safe Work Australia’s Hazardous Substances Information System to determine whether there is an Australian exposure standard for a particular chemical. Where no such exposure standard has been established for Australia, you may submit a value set by an overseas regulatory authority.

2.6.7. Ambient air monitoring

Monitoring of ambient air levels of volatile veterinary chemical products may also be recommended for the assessment of exposures.

2.6.8. Health surveillance

Australian and state or territory law establishes health surveillance requirements for certain substances or substance classes. For information on substances nationally recommended for health surveillance, refer to the current Schedule and guidelines for health surveillance (NOHSC–ASCC 1995).

For new active constituents, you should indicate whether health surveillance is appropriate. If so, provide a biological exposure index, a justification for the index and the proposed monitoring method.

2.6.9. Contraindications

You should list any health or other circumstances that are peculiar to the product and would contraindicate its use in particular circumstances.

3. References

EnHealth 2012, Environmental health risk assessment: guidelines for assessing human health risks from environmental hazards.

IPCS 1993, Environmental Health Criteria 155: Biomarkers and risk assessment: concepts and principles, International Programme on Chemical Safety, World Health Organization, Geneva.

IPCS 1994, Environmental Health Criteria 170: Assessing human health risks of chemicals: derivation of guidance values for health-based exposure limits, International Programme on Chemical Safety, World Health Organization, Geneva.

IPCS 1999, Environmental Health Criteria 210: Principles for the assessment of risks to human health from exposure to chemicals, International Programme on Chemical Safety, World Health Organisation, Geneva.

IPCS 2000, Environmental Health Criteria 214: Human exposure assessment, International Programme on Chemical Safety, World Health Organization, Geneva.

IPCS 2001, Environmental Health Criteria 222, Biomarkers in risk assessment: validity and validation, International Programme on Chemical Safety, World Health Organization, Geneva.

NHMRC 2007, National statement on ethical conduct in research involving humans, National Health and Medical Research Council, Canberra.

Safe Work Australia, 2019, Workplace Exposure Standards for Airborne Contaminants, Safe Work Australia, Canberra.

Safe Work Australia 2013, Guidance note on the interpretation of workplace exposure standards for airborne  contaminants, Safe Work Australia, Canberra.

Safe Work Australia, 2018, Classifying hazardous chemicals National Guide, Safe Work Australia, Canberra.

NOHSC 2007, National code of practice for the control of workplace hazardous substances, 2nd edition, National Occupational Health and Safety Commission, Safe Work Australia, Canberra.

NOHSC–ASCC 1994, National code of practice for the labelling of workplace substances, National Occupational Health and Safety Commission and Australian Safety and Compensation Council, Safe Work Australia, Canberra.

NOHSC–ASCC 1995, Schedule and guidelines for health surveillance, National Occupational Health and Safety Commission and Australian Safety and Compensation Council, Safe Work Australia, Canberra.

Safe Work Australia, 2018, Preparation of safety data sheets for hazardous chemicals Code of Practice, Safe Work Australia, Canberra.

OECD 1997, Guidance document for the conduct of studies of occupational exposure to pesticides during agricultural application, Series on Testing and Assessment no. 9, Environment Directorate, Organisation for Economic Cooperation and Development, Paris.

US EPA 2013, Occupational and residential exposure test guidelines, OCSPP 875 Series, United States Environmental Protection Agency, Washington DC, United States.

WHO/IPCS 2010, Human health risk assessment toolkit: chemical hazards, World Health Organization and International Programme on Chemical Safety.

Content last updated:
Content last reviewed: